Literature DB >> 32927391

New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid.

Diego G Ghiano1, Alejandro Recio-Balsells1, Ana Bortolotti2, Lucas A Defelipe3, Adrián Turjanski3, Héctor R Morbidoni4, Guillermo R Labadie5.   

Abstract

A library of thirty N-substituted tosyl N'-acryl-hydrazones was prepared with p-toluenesulfonyl hydrazide, methyl propiolate and different aldehydes in a one-pot synthesis via an aza-Michael reaction. The scope of the reaction was studied, including aliphatic, isoprenylic, aromatic and carbocyclic aldehydes. The prepared collection was tested against Mycobacterium tuberculosis H37Rv. Nine analogs of the collection showed Minimum Inhibitory Concentration ≤10 μM, of which the most active members (MIC of 1.25 μM) were exclusively E isomers. In order to validate the mechanism of action of the most active acrylates, we tested their activity on a M. tuberculosis InhA over-expressing strain obtaining MIC that consistently doubled those obtained on the wild type strain. Additionally, the binding mode of those analogs on M. tuberculosis InhA was investigated by docking simulations. The results displayed a hydrogen bond interaction between the sulfonamide and Ile194 and the carbonyl of the methyl ester with Tyr 158 (both critical residues in the interaction with the fatty acyl chain substrate), where the main differences on the binding mode relays on the hydrophobicity of the nitrogen substituent. Additionally, chemoinformatic analysis was performed to evaluate in silico possible cytotoxicity risk and ADME-Tox profile. Based on their simple preparation and interesting antimycobacterial activity profile, the newly prepared aza-acrylates are promising candidates for antitubercular drug development.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aza-Michael; Chemoinformatics; Docking; InhA; One-pot; Tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 32927391     DOI: 10.1016/j.ejmech.2020.112699

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives.

Authors:  Violina T Angelova; Tania Pencheva; Nikolay Vassilev; Elena K-Yovkova; Rositsa Mihaylova; Boris Petrov; Violeta Valcheva
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid.

Authors:  Sana Yaqoob; Nourina Nasim; Rahila Khanam; Yan Wang; Almas Jabeen; Urooj Qureshi; Zaheer Ul-Haq; Hesham R El-Seedi; Zi-Hua Jiang; Farooq-Ahmad Khan
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.